Arrivent Biopharma, Inc.: Clear Street cuts target price to $22 from $47
AVBP•Clear Street cut its target price for Arrivent Biopharma to $22 from $47.
Related News
Penguin Solutions Inc: Rosenblatt Securities raises target price to $100 from $80
PENG•
IEA to meet Wednesday over proposed release of oil and diesel stocks, diplomats say
USO•
SM Energy Co: Truist Securities raises target price to $48 from $43
SM•
Allegiant Travel Company: Raymond James cuts target price to $110 from $116
ALGT•
FedEx: Truist Securities cuts target price to $350 from $365
FDX•